Biohaven (NYSE:BHVN) reported quarterly losses of $(1.21) per share which missed the analyst consensus estimate of $(1.06) by 14.15 percent. This is a 29.24 percent increase over losses of $(1.71) per share from the same period last year.
Biohaven (NYSE:BHVN) reported quarterly losses of $(1.21) per share which missed the analyst consensus estimate of $(1.06) by 14.15 percent. This is a 29.24 percent increase over losses of $(1.71) per share from the same period last year.
Comments